GaviLyte-C Side Effects
Generic name: polyethylene glycol 3350 with electrolytes
Medically reviewed by Drugs.com. Last updated on Dec 7, 2023.
Note: This document provides detailed information about GaviLyte-C Side Effects associated with polyethylene glycol 3350 with electrolytes. Some dosage forms listed on this page may not apply specifically to the brand name GaviLyte-C.
Applies to polyethylene glycol 3350 with electrolytes: oral powder for solution.
Serious side effects of GaviLyte-C
Along with its needed effects, polyethylene glycol 3350 with electrolytes (the active ingredient contained in GaviLyte-C) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking polyethylene glycol 3350 with electrolytes:
More common
- full or bloated feeling
- pain in the upper stomach
- pressure in the stomach
- stomach pain
- swelling of the stomach area
- vomiting
Rare
- confusion
- decreased urine output
- dizziness
- dry mouth
- fast or irregular heartbeat
- headache
- increased thirst
- loss of appetite
- loss of consciousness
- muscle pain or cramps
- numbness or tingling in the hands, feet, fingertips, lips, or mouth
- seizures
- swelling of the face, ankles, or hands
- unusual tiredness or weakness
Incidence not known
- blistering, crusting, irritation, itching, or reddening of the skin
- bloating or swelling of the face, arms, hands, lower legs, or feet
- bloody or black, tarry stools
- bloody urine
- blue lips and fingernails
- blurred vision
- chest pain or tightness
- chills
- constipation
- cough
- coughing that sometimes produces a pink frothy sputum
- cracked, dry, scaly skin
- difficult, fast, noisy breathing
- difficulty swallowing
- fainting
- fast, pounding, or irregular heartbeat or pulse
- fever
- heartburn
- hives, itching, skin rash
- increase in heart rate
- increased sweating
- lightheadedness
- lower back or side pain
- nausea
- nervousness
- pale skin
- pounding in the ears
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- rapid breathing
- rapid weight gain
- runny nose
- severe stomach pain
- slow heartbeat
- sunken eyes
- swelling of the neck
- thirst
- throat tightness
- tingling of the hands or feet
- tremor
- trouble breathing
- unusual weight gain or loss
- vomiting of blood or material that looks like coffee grounds
- wrinkled skin
Other side effects of GaviLyte-C
Some side effects of polyethylene glycol 3350 with electrolytes may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- burning, itching, or pain around the anus
- difficulty with sleeping
- feeling unusually cold
- general feeling of discomfort or illness
- hunger
- shivering
Less common
- belching
- indigestion
- stomach discomfort or upset
For healthcare professionals
Applies to polyethylene glycol 3350 with electrolytes: oral kit, oral powder for reconstitution.
General
The most common adverse events were abdominal distension, anal discomfort, thirst, nausea, and abdominal pain. Since diarrhea is considered part of the efficacy of this product, it was not defined as an adverse reaction.[Ref]
Gastrointestinal
- Very common (10% or more): Abdominal distension (59.8%), anal discomfort (52%), nausea (47.3%), abdominal pain (39.1%), vomiting (12.8%)
- Common (1% to 10%): Upper abdominal pain, dyspepsia
- Frequency not reported: Upper gastrointestinal bleeding from a Mallory-Weiss tear, esophageal perforation, borborygmi, flatulence[Ref]
Metabolic
- Very common (10% or more): Hunger (70.8%)
- Common (1% to 10%): Hypokalemia, hyperphosphatemia
- Frequency not reported: Electrolyte disturbances, hyperkalemia[Ref]
Other
- Very common (10% or more): Rigors (33.7%), malaise (26.6%)
- Frequency not reported: Peripheral edema[Ref]
Nervous system
- Very common (10% or more): Dizziness (18.1%)
- Common (1% to 10%): Headache[Ref]
Psychiatric
- Very common (10% or more): Sleep disorder (34.9%)[Ref]
Hypersensitivity
- Frequency not reported: Anaphylactic reaction
- Postmarketing reports: Hypersensitivity reactions (including anaphylaxis, rash, angioedema, urticaria, lip and facial swelling, dyspnea, chest tightness, throat tightness)[Ref]
Cardiovascular
- Frequency not reported: Asystole[Ref]
Dermatologic
- Frequency not reported: Urticaria, dermatitis[Ref]
Respiratory
- Frequency not reported: Rhinorrhea, acute pulmonary edema, acute pulmonary edema after aspirating the PEG-based preparation[Ref]
References
1. "Product Information. Golytely (polyethylene glycol 3350 with electrolytes)." Braintree
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. (2016) "Product Information. MoviPrep (polyethylene glycol 3350 with electrolytes)." Physicians Total Care
5. (2016) "Product Information. TriLyte with Flavor Packs (polyethylene glycol 3350 with electrolytes)." Alaven Pharmaceuticals
6. (2016) "Product Information. Colyte with Flavor Packs (polyethylene glycol 3350 with electrolytes)." Alaven Pharmaceuticals
More about GaviLyte-C (polyethylene glycol 3350 with electrolytes)
- Check interactions
- Compare alternatives
- Reviews (16)
- Dosage information
- During pregnancy
- Drug class: laxatives
Patient resources
Other brands
GoLYTELY, Plenvu, PEG-3350 with Electolytes, Suflave, ... +4 more
Professional resources
Other brands
GoLYTELY, Plenvu, Suflave, NuLYTELY, ... +3 more
Other formulations
Related treatment guides
Further information
GaviLyte-C side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.